(Q44322914)

2 December 2017

Whole bladder photodynamic therapy with 5-aminolevulinic acid using a white light source (English)

1 reference

2 December 2017

1 reference

3

Knüchel R

1 reference

2 December 2017

Waidelich R

1

1 reference

2 December 2017

Beyer W

2

1 reference

2 December 2017

Stepp H

4

1 reference

2 December 2017

Baumgartner R

5

1 reference

2 December 2017

Schröder J

6

1 reference

2 December 2017

Hofstetter A

7

1 reference

2 December 2017

Kriegmair M

8

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

2 December 2017

1 reference

2 December 2017

61

1 reference

2 December 2017

332-337

1 reference

2 December 2017

2

1 reference

Clinical experience with the integral photodynamic therapy of bladder carcinoma

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902164-7

7 January 2021

Long-term results of whole bladder wall photodynamic therapy for carcinoma in situ of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902164-7

7 January 2021

Phase I trial of photodynamic therapy in the treatment of recurrent superficial transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902164-7

7 January 2021

Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902164-7

7 January 2021

Hematoporphyrin Derivative: A Possible Aid in the Diagnosis and Therapy of Carcinoma of the Bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902164-7

7 January 2021

Endoscopic detection of transitional cell carcinoma with 5-aminolevulinic acid: results of 1012 fluorescence endoscopies

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902164-7

7 January 2021

Whole bladder photodynamic therapy: critical review of present-day technology and rationale for development of intravesical laser catheter and monitoring system

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902164-7

7 January 2021

Intravesical instillation of 5-aminolevulinic acid: the fluorescent metabolite is limited to urothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902164-7

7 January 2021

Photodynamic therapy on rat urinary bladder with intravesical instillation of 5-aminolevulinic acid: light diffusion and histological changes

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902164-7

7 January 2021

Optimization of differential photodynamic effectiveness between normal and tumor urothelial cells using 5-aminolevulinic acid-induced protoporphyrin IX as sensitizer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902164-7

7 January 2021

The morphological changes in rat bladder after photodynamic therapy with 5-aminolaevulinic acid-induced protoporphyrin IX.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902164-7

7 January 2021

Photosensitization of murine tumor, vasculature and skin by 5-aminolevulinic acid-induced porphyrin.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902164-7

7 January 2021

5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902164-7

7 January 2021

The role of photodynamic therapy in the treatment of recurrent superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902164-7

7 January 2021

Hemodynamic effects of 5-aminolevulinic acid in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902164-7

7 January 2021

Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of upper tract urothelial tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902164-7

7 January 2021

The metabolism of delta -aminolaevulic acid. 1. Normal pathways, studied with the aid of 15N.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902164-7

7 January 2021

Clinical pharmacokinetics of 5-aminolevulinic acid in healthy volunteers and patients at high risk for recurrent bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902164-7

7 January 2021

10.1016/S0090-4295(02)02164-7

Identifiers

DOI

1 reference

2 December 2017

1 reference